Estrogens and surgery in women with von Willebrand's disease

Jack B. Alperin

Research output: Contribution to journalArticle

Abstract

While receiving estrogen therapy, three women with classic type I von Willebrand's disease showed significantly less bleeding and improved hemostasis. One took estrogens to prevent menopausal symptoms, and two used oral contraceptives. These women underwent major surgery without excessive bleeding and without requiring cryoprecipitate or other blood components. Prior to estrogen therapy, each woman had received cryoprecipitate or fresh frozen plasma to stop bleeding from dental extractions or other surgical procedures. Furthermore, two other women with type I von Willebrand's disease also exhibited improved hemostasis while taking oral contraceptives. These experiences suggest a short course of estrogen therapy may effectively prepare some women with von Willebrand's disease for elective surgery.

Original languageEnglish (US)
Pages (from-to)322-327
Number of pages6
JournalThe American Journal of Medicine
Volume73
Issue number3
DOIs
StatePublished - 1982
Externally publishedYes

Fingerprint

von Willebrand Diseases
Estrogens
Type 1 von Willebrand Disease
Hemorrhage
Oral Contraceptives
Hemostasis
Tooth Extraction
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Estrogens and surgery in women with von Willebrand's disease. / Alperin, Jack B.

In: The American Journal of Medicine, Vol. 73, No. 3, 1982, p. 322-327.

Research output: Contribution to journalArticle

Alperin, Jack B. / Estrogens and surgery in women with von Willebrand's disease. In: The American Journal of Medicine. 1982 ; Vol. 73, No. 3. pp. 322-327.
@article{50fef0b8ed6943a281ec3f2ed060fa73,
title = "Estrogens and surgery in women with von Willebrand's disease",
abstract = "While receiving estrogen therapy, three women with classic type I von Willebrand's disease showed significantly less bleeding and improved hemostasis. One took estrogens to prevent menopausal symptoms, and two used oral contraceptives. These women underwent major surgery without excessive bleeding and without requiring cryoprecipitate or other blood components. Prior to estrogen therapy, each woman had received cryoprecipitate or fresh frozen plasma to stop bleeding from dental extractions or other surgical procedures. Furthermore, two other women with type I von Willebrand's disease also exhibited improved hemostasis while taking oral contraceptives. These experiences suggest a short course of estrogen therapy may effectively prepare some women with von Willebrand's disease for elective surgery.",
author = "Alperin, {Jack B.}",
year = "1982",
doi = "10.1016/0002-9343(82)90717-3",
language = "English (US)",
volume = "73",
pages = "322--327",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Estrogens and surgery in women with von Willebrand's disease

AU - Alperin, Jack B.

PY - 1982

Y1 - 1982

N2 - While receiving estrogen therapy, three women with classic type I von Willebrand's disease showed significantly less bleeding and improved hemostasis. One took estrogens to prevent menopausal symptoms, and two used oral contraceptives. These women underwent major surgery without excessive bleeding and without requiring cryoprecipitate or other blood components. Prior to estrogen therapy, each woman had received cryoprecipitate or fresh frozen plasma to stop bleeding from dental extractions or other surgical procedures. Furthermore, two other women with type I von Willebrand's disease also exhibited improved hemostasis while taking oral contraceptives. These experiences suggest a short course of estrogen therapy may effectively prepare some women with von Willebrand's disease for elective surgery.

AB - While receiving estrogen therapy, three women with classic type I von Willebrand's disease showed significantly less bleeding and improved hemostasis. One took estrogens to prevent menopausal symptoms, and two used oral contraceptives. These women underwent major surgery without excessive bleeding and without requiring cryoprecipitate or other blood components. Prior to estrogen therapy, each woman had received cryoprecipitate or fresh frozen plasma to stop bleeding from dental extractions or other surgical procedures. Furthermore, two other women with type I von Willebrand's disease also exhibited improved hemostasis while taking oral contraceptives. These experiences suggest a short course of estrogen therapy may effectively prepare some women with von Willebrand's disease for elective surgery.

UR - http://www.scopus.com/inward/record.url?scp=49049139372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49049139372&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(82)90717-3

DO - 10.1016/0002-9343(82)90717-3

M3 - Article

AN - SCOPUS:49049139372

VL - 73

SP - 322

EP - 327

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 3

ER -